Used in pharmaceutical research as a potent and selective agonist for serotonin receptors, particularly 5-HT1B and 5-HT1D, showing potential in the treatment of migraine and other neurological disorders. Its structure enables high blood-brain barrier penetration, making it suitable for central nervous system-targeted therapies. Also investigated for its role in modulating neurotransmitter release, which may contribute to anti-inflammatory and neuroprotective effects. Commonly employed in preclinical studies to evaluate receptor activation and downstream signaling pathways.